Brief: PolyPeptide Group FY EBITDA EUR -5.999 Million
12/03/2024 06:08
Mar 12 (Reuters) - PolyPeptide Group FY capex EUR 54.89 million. * FY EBITDA EUR -5.999 million * FY EBIT EUR -36.468 million * FY revenue EUR 320.372 million vs. IBES estimate EUR 293 million * FY cash flow from operating activities EUR 36.485 million
Recent news on PolyPeptide AG
See all newsBrief: Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Brief: Polypeptide Group Provisional Interim Result Of The Public Tender Offer Of Samsung Biologics Co
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Samsung Biologics to launch takeover bid for PolyPeptide in September (updated)